B. Bongenya, C. Tshinguta, M. Sombo, G. Bumoko, B. Kabengele, G. Mesia, E. Kamangu
{"title":"在刚果民主共和国金沙萨开始以多来替韦为基础的抗逆转录病毒治疗的人类免疫缺陷病毒感染者的病毒学和分子特征","authors":"B. Bongenya, C. Tshinguta, M. Sombo, G. Bumoko, B. Kabengele, G. Mesia, E. Kamangu","doi":"10.4236/wja.2023.133008","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":58633,"journal":{"name":"艾滋病(英文)","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Virological and Molecular Profile of People Living with the Human Immunodeficiency Virus Starting Dolutegravir Based Antiretroviral Treatment in Kinshasa, Democratic Republic of Congo\",\"authors\":\"B. Bongenya, C. Tshinguta, M. Sombo, G. Bumoko, B. Kabengele, G. Mesia, E. Kamangu\",\"doi\":\"10.4236/wja.2023.133008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":58633,\"journal\":{\"name\":\"艾滋病(英文)\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"艾滋病(英文)\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4236/wja.2023.133008\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"艾滋病(英文)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4236/wja.2023.133008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Virological and Molecular Profile of People Living with the Human Immunodeficiency Virus Starting Dolutegravir Based Antiretroviral Treatment in Kinshasa, Democratic Republic of Congo